Literature DB >> 15361494

Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women.

A Yeo1, P Boyd, S Lumsden, T Saunders, A Handley, M Stubbins, A Knaggs, S Asquith, I Taylor, B Bahari, N Crocker, R Rallan, S Varsani, D Montgomery, D H Alpers, G E Dukes, I Purvis, G A Hicks.   

Abstract

BACKGROUND AND AIMS: Serotonin (5-hydroxtryptamine, 5-HT) is an important factor in gut function, playing key roles in intestinal peristalsis and secretion, and in sensory signalling in the brain-gut axis. Removal from its sites of action is mediated by a specific protein called the serotonin reuptake transporter (SERT or 5-HTT). Polymorphisms in the promoter region of the SERT gene have effects on transcriptional activity, resulting in altered 5-HT reuptake efficiency. It has been speculated that such functional polymorphisms may underlie disturbance in gut function in individuals suffering with disorders such as irritable bowel syndrome (IBS). The aim of this study was to assess the potential association between SERT polymorphisms and the diarrhoea predominant IBS (dIBS) phenotype.
SUBJECTS: A total of 194 North American Caucasian female dIBS patients and 448 female Caucasian controls were subjected to genotyping.
METHODS: Leucocyte DNA of all subjects was analysed by polymerase chain reaction based technologies for nine SERT polymorphisms, including the insertion/deletion polymorphism in the promoter (SERT-P) and the variable tandem repeat in intron 2. Statistical analysis was performed to assess association of any SERT polymorphism allele with the dIBS phenotype.
RESULTS: A strong genotypic association was observed between the SERT-P deletion/deletion genotype and the dIBS phenotype (p = 3.07x10(-5); n = 194). None of the other polymorphisms analysed was significantly associated with the presence of disease.
CONCLUSIONS: Significant association was observed between dIBS and the SERT-P deletion/deletion genotype, suggesting that the serotonin transporter is a potential candidate gene for dIBS in women.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361494      PMCID: PMC1774243          DOI: 10.1136/gut.2003.035451

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  61 in total

Review 1.  Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel.

Authors:  M D Gershon
Journal:  Aliment Pharmacol Ther       Date:  1999-05       Impact factor: 8.171

2.  Population studies of polymorphisms of the serotonin transporter protein gene.

Authors:  J Gelernter; J F Cubells; J R Kidd; A J Pakstis; K K Kidd
Journal:  Am J Med Genet       Date:  1999-02-05

3.  Alternative splicing of the human serotonin transporter gene.

Authors:  C C Bradley; R D Blakely
Journal:  J Neurochem       Date:  1997-10       Impact factor: 5.372

4.  Effect of granisetron on cholera toxin-induced enteric secretion.

Authors:  J L Turvill; M J Farthing
Journal:  Lancet       Date:  1997-05-03       Impact factor: 79.321

5.  Refined mapping of the human serotonin transporter (SLC6A4) gene within 17q11 adjacent to the CPD and NF1 genes.

Authors:  S Shen; S Battersby; M Weaver; E Clark; K Stephens; A J Harmar
Journal:  Eur J Hum Genet       Date:  2000-01       Impact factor: 4.246

6.  Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters.

Authors:  J J Chen; Z Li; H Pan; D L Murphy; H Tamir; H Koepsell; M D Gershon
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

7.  Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects.

Authors:  J Gelernter; H Kranzler; J F Cubells
Journal:  Hum Genet       Date:  1997-12       Impact factor: 4.132

8.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

9.  Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.

Authors:  S Ramamoorthy; A L Bauman; K R Moore; H Han; T Yang-Feng; A S Chang; V Ganapathy; R D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

10.  Guinea pig 5-HT transporter: cloning, expression, distribution, and function in intestinal sensory reception.

Authors:  J X Chen; H Pan; T P Rothman; P R Wade; M D Gershon
Journal:  Am J Physiol       Date:  1998-09
View more
  78 in total

Review 1.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors:  Michael Camilleri; David A Katzka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

Review 2.  Is there a SERT-ain association with IBS?

Authors:  M Camilleri
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

Review 3.  IBS: An epigenetic perspective.

Authors:  Timothy G Dinan; John Cryan; Fergus Shanahan; P W Napoleon Keeling; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06-29       Impact factor: 46.802

Review 4.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

Review 5.  Genetic approaches to functional gastrointestinal disorders.

Authors:  Yuri A Saito; Nandita Mitra; Emeran A Mayer
Journal:  Gastroenterology       Date:  2010-02-19       Impact factor: 22.682

Review 6.  Irritable bowel syndrome and functional dyspepsia: different diseases or a single disorder with different manifestations?

Authors:  Laura Noddin; Michael Callahan; Brian E Lacy
Journal:  MedGenMed       Date:  2005-08-29

Review 7.  Genes and environment in irritable bowel syndrome: one step forward.

Authors:  N J Talley
Journal:  Gut       Date:  2006-12       Impact factor: 23.059

8.  Role of corticotropin-releasing factor in stress-related visceral hyperalgesia.

Authors:  Hiroshi Kaneko
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

Review 9.  Pathophysiology of fibromyalgia.

Authors:  Laurence A Bradley
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

10.  The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling.

Authors:  Yingcong Yu; Shujuan Wu; Jianxin Li; Renye Wang; Xupei Xie; Xuefeng Yu; Jianchun Pan; Ying Xu; Liang Zheng
Journal:  Metab Brain Dis       Date:  2014-05-08       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.